Remus Pharmaceuticals

2,004.95
-10.55
(-0.52%)
Market Cap
1,181.30 Cr
EPS
152.01
PE Ratio
40.64
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
7,743.85
52 Week Low
1,785.10
PB Ratio
4.62
Debt to Equity
0.13
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,683.60
#1 4,03,952.00
35.21
#1 49,887.20
12.06
#1 9,648
-18.99
40.74
6,483.00
1,72,103.30
78.53
8,184.00
0.89
1,600
23.05
63.44
1,484.20
1,19,866.20
22.74
26,520.70
14.17
4,155
30.28
47.86
3,174.70
1,07,446.30
55.70
10,785.70
11.59
1,656
10.91
43.82
1,230.10
1,02,646.40
#1 18.15
28,905.40
12.36
5,578
21.14
62.40
2,432.40
1,00,355.60
50.56
10,615.60
19.57
1,942
-10.91
44.37
908.60
91,426.40
19.56
19,831.50
13.82
3,831
-0.19
56.78
1,978.90
90,344.90
27.54
20,141.50
#1 19.94
1,936
#1 112.49
44.10
1,197.10
69,527.80
19.71
29,559.20
17.55
3,169
-10.04
50.83
30,795.00
65,437.20
46.30
6,097.20
10.80
1,201
27.83
54.40

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
44.17 %
Net Income Growth
97.81 %
Cash Flow Change
690.16 %
ROE
-53.87 %
ROCE
-2.48 %
EBITDA Margin (Avg.)
35.81 %

Yearly Financial Results

Annual Financials
2024
TTM
Revenue
218
0
Expenses
185
0
EBITDA
33
0
Operating Profit %
13 %
0 %
Depreciation
1
0
Interest
1
0
Profit Before Tax
32
0
Tax
6
0
Net Profit
26
0
EPS in ₹
152.01
0.00

Balance Sheet

Balance Sheet
2024
Total Assets
257
Fixed Assets
12
Current Assets
210
Capital Work in Progress
0
Investments
3
Other Assets
243
Total Liabilities
257
Current Liabilities
150
Non Current Liabilities
4
Total Equity
104
Reserve & Surplus
85
Share Capital
2

Cash Flow

Cash Flow
2024
Net Cash Flow
19
Investing Activities
-9
Operating Activities
4
Financing Activities
24

Share Holding

% Holding
Mar 2023
May 2023
Sept 2023
Mar 2024
Jun 2024
Sept 2024
Mar 2025
Promoter
92.82 %
68.37 %
69.61 %
70.60 %
70.66 %
70.84 %
70.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.92 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.44 %
16.69 %
21.15 %
20.54 %
20.90 %
20.49 %
19.18 %
Others
0.74 %
14.02 %
9.24 %
8.85 %
8.44 %
8.67 %
9.97 %
No of Share Holders
30
1,743
856
1,124
1,577
1,753
398

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 1,832.50 2,207.70
20 Nov 2024 DIVIDEND Dividend
₹ 1.00 /share
19 Nov 2024 2,536.65 2,356.45
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 2,542.60 2,536.65
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 2,621.65 2,410.90
06 Jun 2024 BONUS Bonus
3:1
06 Jun 2024 7,200.25 7,227.95
21 May 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 May 2024 6,340.10 7,948.30
02 May 2024 DIVIDEND Dividend
₹ 4.00 /share
02 May 2024 6,340.10 7,369.00
13 Mar 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
13 Mar 2024 6,925.75 5,440.90
28 Oct 2023 DIVIDEND Dividend
₹ 2.00 /share
27 Oct 2023 5,493.50 5,599.00
15 Sept 2023 DIVIDEND Dividend
₹ 2.00 /share
15 Sept 2023 0.00 4,172.50

Technical Indicators

RSI(14)
Neutral
47.98
ATR(14)
Less Volatile
83.45
STOCH(9,6)
Neutral
52.07
STOCH RSI(14)
Neutral
46.75
MACD(12,26)
Bullish
5.67
ADX(14)
Weak Trend
18.12
UO(9)
Bearish
49.04
ROC(12)
Uptrend And Accelerating
4.70
WillR(14)
Neutral
-60.36